Kiora Financial Statements From 2010 to 2026

KPRX Stock  USD 2.19  0.07  3.30%   
Kiora Pharmaceuticals' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Kiora Pharmaceuticals' valuation are provided below:
Gross Profit
-3.7 M
Market Capitalization
7.8 M
Enterprise Value Revenue
569.4141
Earnings Share
(2.19)
We have found one hundred twenty available fundamental ratios for Kiora Pharmaceuticals, which can be analyzed and compared to other ratios and to its peers in the industry. All investors should make sure to check all of Kiora Pharmaceuticals last-minute market performance against the performance between 2010 and 2026 to make sure the company can sustain itself down the road. Market Cap is likely to drop to about 14 M in 2026. Enterprise Value is likely to drop to about 9.9 M in 2026

Kiora Pharmaceuticals Total Revenue

19.32 Million

Check Kiora Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Kiora Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 41.1 K, Selling General Administrative of 4.9 M or Other Operating Expenses of 10.7 M, as well as many indicators such as Price To Sales Ratio of 0.68, Dividend Yield of 0.0 or PTB Ratio of 0.47. Kiora financial statements analysis is a perfect complement when working with Kiora Pharmaceuticals Valuation or Volatility modules.
  
Build AI portfolio with Kiora Stock
Check out the analysis of Kiora Pharmaceuticals Correlation against competitors.
For more information on how to buy Kiora Stock please use our How to Invest in Kiora Pharmaceuticals guide.

Kiora Pharmaceuticals Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets44.1 M42 M15.1 M
Slightly volatile
Short and Long Term Debt Total48.9 K51.5 K391.3 K
Slightly volatile
Other Current Liabilities6.7 M6.4 M2.1 M
Slightly volatile
Total Current Liabilities3.3 M5.4 M3.8 M
Pretty Stable
Property Plant And Equipment Net83.8 K71.8 K66.2 K
Slightly volatile
Accounts Payable484.4 K477.9 K406.3 K
Pretty Stable
Cash4.7 M4.4 MM
Slightly volatile
Non Current Assets Total6.4 M7.8 M5.4 M
Slightly volatile
Non Currrent Assets Other8.1 M7.7 M1.5 M
Slightly volatile
Cash And Short Term Investments32.4 M30.8 M8.6 M
Slightly volatile
Net Receivables488.9 K691.4 K413.8 K
Slightly volatile
Common Stock Shares OutstandingM4.7 M924.2 K
Slightly volatile
Liabilities And Stockholders Equity44.1 M42 M15.1 M
Slightly volatile
Non Current Liabilities TotalM4.2 M13.1 M
Slightly volatile
Other Current Assets2.8 M2.7 M758.6 K
Slightly volatile
Other Stockholder Equity103.5 M194.5 M90.7 M
Slightly volatile
Total Liabilities11.9 M9.7 M17 M
Slightly volatile
Total Current Assets35.9 M34.2 M9.7 M
Slightly volatile
Short Term Debt20 K21 K356.3 K
Slightly volatile
Common Stock323.2 K307.8 K111.2 K
Slightly volatile
Current Deferred Revenue4.9 M3.1 M2.9 M
Slightly volatile
Intangible Assets8.1 M7.7 M6.7 M
Slightly volatile
Other Liabilities8.6 M8.2 M3.9 M
Slightly volatile
Capital Lease Obligations91.8 K65.7 K55.2 K
Slightly volatile
Deferred Long Term Liabilities6.6 M9.8 M5.8 M
Slightly volatile
Non Current Liabilities Other3.9 M4.8 M2.7 M
Slightly volatile
Property Plant Equipment342.2 K325.9 K137.6 K
Slightly volatile
Capital Stock253 K240.9 K295.4 K
Slightly volatile
Property Plant And Equipment Gross54.2 K57.1 K123.6 K
Pretty Stable
Long Term Debt222.6 K250.4 K273.3 K
Slightly volatile
Short and Long Term Debt169.8 K191.1 K208.5 K
Slightly volatile
Inventory0.80.90.9824
Slightly volatile

Kiora Pharmaceuticals Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization41.1 K22.1 K33.4 K
Slightly volatile
Selling General Administrative4.9 M6.4 M4.4 M
Slightly volatile
Other Operating Expenses10.7 M13.2 M9.6 M
Slightly volatile
Research Development5.1 M5.6 M4.6 M
Slightly volatile
Total Operating Expenses10.5 M13.2 M9.4 M
Slightly volatile
Interest Expense18.3 K19.3 K289.1 K
Slightly volatile
Cost Of Revenue324.5 K341.6 K2.1 M
Very volatile
Interest Income1.5 M1.4 M276.3 K
Slightly volatile
Reconciled Depreciation16.4 K17.3 K37.3 K
Pretty Stable
Selling And Marketing Expenses49.9 K56.2 K61.3 K
Slightly volatile

Kiora Pharmaceuticals Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation709.2 K755.1 K625.8 K
Slightly volatile
Begin Period Cash FlowM2.8 M4.8 M
Pretty Stable
Depreciation41.1 K22.1 K33.4 K
Slightly volatile
End Period Cash Flow4.7 M4.4 MM
Slightly volatile
Issuance Of Capital Stock9.8 M17.2 M10 M
Pretty Stable
Dividends Paid5.9 K6.6 K7.2 K
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio0.680.721.1 K
Very volatile
Days Sales Outstanding11.7312.34180
Very volatile
Average Payables677.7 K672.1 K721 K
Slightly volatile
Stock Based Compensation To Revenue0.03510.03694.0347
Very volatile
Capex To Depreciation0.360.371.6532
Slightly volatile
EV To Sales0.480.511.1 K
Very volatile
Payables Turnover6.446.7711.6493
Very volatile
Sales General And Administrative To Revenue0.30.3125.1886
Very volatile
Research And Ddevelopement To Revenue0.260.2824.5768
Very volatile
Capex To Revenue3.0E-44.0E-40.2177
Very volatile
Cash Per Share7.567.96141
Slightly volatile
Days Payables Outstanding52.9755.7643.8 K
Slightly volatile
Income Quality2.252.141.0624
Slightly volatile
Intangibles To Total Assets0.460.580.5623
Pretty Stable
Current Ratio4.674.452.5543
Slightly volatile
Receivables Turnover22.7523.9552.9511
Very volatile
Graham Number9.4310.6111.5788
Slightly volatile
Capex Per Share0.00180.00190.7044
Slightly volatile
Average Receivables899 K856.2 K513.9 K
Slightly volatile
Revenue Per Share4.514.7524.8796
Slightly volatile
Interest Debt Per Share0.02220.023348.3632
Slightly volatile
Debt To Assets0.00170.00180.3138
Slightly volatile
Operating Cycle11.7312.34180
Very volatile
Days Of Payables Outstanding52.9755.7643.8 K
Slightly volatile
Ebt Per Ebit0.821.131.0191
Pretty Stable
Long Term Debt To Capitalization0.02220.0250.0273
Slightly volatile
Quick Ratio4.674.452.5543
Slightly volatile
Net Income Per E B T1.080.730.9755
Slightly volatile
Cash Ratio0.540.571.5831
Pretty Stable
Days Of Sales Outstanding11.7312.34180
Very volatile
Free Cash Flow Operating Cash Flow Ratio1.111.151.0182
Slightly volatile
Fixed Asset Turnover242231107
Slightly volatile
Debt Ratio0.00170.00180.3138
Slightly volatile
Price Sales Ratio0.680.721.1 K
Very volatile
Asset Turnover0.410.390.2027
Slightly volatile

Kiora Pharmaceuticals Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap14 M14.7 M114.2 M
Slightly volatile
Enterprise Value9.9 M10.4 M108.3 M
Slightly volatile

Kiora Fundamental Market Drivers

Forward Price Earnings2.4102
Cash And Short Term Investments26.8 M

Kiora Upcoming Events

28th of March 2024
Upcoming Quarterly Report
View
14th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
28th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Kiora Pharmaceuticals Financial Statements

Kiora Pharmaceuticals investors use historical fundamental indicators, such as Kiora Pharmaceuticals' revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Kiora Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue3.1 M4.9 M
Cost Of Revenue341.6 K324.5 K
Total Revenue18.4 M19.3 M
Stock Based Compensation To Revenue 0.04  0.04 
Sales General And Administrative To Revenue 0.31  0.30 
Research And Ddevelopement To Revenue 0.28  0.26 
Revenue Per Share 4.75  4.51 
Ebit Per Revenue 0.32  0.34 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Kiora Stock Analysis

When running Kiora Pharmaceuticals' price analysis, check to measure Kiora Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kiora Pharmaceuticals is operating at the current time. Most of Kiora Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Kiora Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kiora Pharmaceuticals' price. Additionally, you may evaluate how the addition of Kiora Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.